On Tuesday, Evolus Inc (NASDAQ: EOLS) opened higher 3.80% from the last session, before settling in for the closing price of $9.22. Price fluctuations for EOLS have ranged from $8.67 to $17.82 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 23.91% over the last five years. Company’s average yearly earnings per share was noted 38.27% at the time writing. With a float of $57.03 million, this company’s outstanding shares have now reached $64.45 million.
The firm has a total of 332 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.73%, operating margin of -14.2%, and the pretax margin is -20.19%.
Evolus Inc (EOLS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Evolus Inc is 11.55%, while institutional ownership is 84.22%. The most recent insider transaction that took place on Jun 13 ’25, was worth 1,119,141. In this transaction an insider of this company sold 111,323 shares at a rate of $10.05, taking the stock ownership to the 381,509 shares. Before that another transaction happened on Jun 16 ’25, when Company’s insider sold 16,582 for $9.89, making the entire transaction worth $164,054. This insider now owns 364,927 shares in total.
Evolus Inc (EOLS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 38.27% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Check out the current performance indicators for Evolus Inc (EOLS). In the past quarter, the stock posted a quick ratio of 2.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 0.60 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Analysing the last 5-days average volume posted by the [Evolus Inc, EOLS], we can find that recorded value of 0.69 million was lower than the volume posted last year of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 28.06%.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 14.35%, which indicates a significant decrease from 55.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.32 in the past 14 days, which was lower than the 0.57 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.58, while its 200-day Moving Average is $12.21. Now, the first resistance to watch is $9.78. This is followed by the second major resistance level at $9.99. The third major resistance level sits at $10.29. If the price goes on to break the first support level at $9.27, it is likely to go to the next support level at $8.97. Now, if the price goes above the second support level, the third support stands at $8.76.
Evolus Inc (NASDAQ: EOLS) Key Stats
There are currently 64,476K shares outstanding in the company with a market cap of 617.03 million. Presently, the company’s annual sales total 266,270 K according to its annual income of -50,420 K. Last quarter, the company’s sales amounted to 68,520 K and its income totaled -18,890 K.
